hydroxychloroquine has been researched along with carfilzomib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baranowska, K; Bjørkøy, G; Buene, G; Darvekar, S; Holien, T; Johansson, I; Misund, K; Starheim, KK; Sundan, A; Waage, A | 1 |
1 other study(ies) available for hydroxychloroquine and carfilzomib
Article | Year |
---|---|
Hydroxychloroquine potentiates carfilzomib toxicity towards myeloma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Autophagy; Bortezomib; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Inhibitors; Humans; Hydroxychloroquine; Lysosomes; Macrolides; Microscopy, Confocal; Microscopy, Fluorescence; Multiple Myeloma; Oligopeptides; Primary Cell Culture; Proteasome Endopeptidase Complex; Proteolysis; Sequestosome-1 Protein | 2016 |